As of Jun 20
| -0.33 / -4.08%|
The 1 analysts offering 12-month price forecasts for Clinuvel Pharmaceuticals Ltd have a median target of 25.66, with a high estimate of 25.66 and a low estimate of 25.66. The median estimate represents a +231.05% increase from the last price of 7.75.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.